CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) — CVRx, Inc. (CVRx), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular…

Click here to view the original article.